Purinergic receptors and atherosclerosis: emerging role for vessel wall P2Y12

被引：9
|
作者：
Rauch, Bernhard H. [1 ]
Filep, Janos G. [2 ,3 ]
机构：
[1] Univ Med Greifswald, Inst Pharmacol, Ctr Drug Absorpt & Transport, D-17487 Greifswald, Germany
[2] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H1T 2M4, Canada
[3] Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada
来源：
CARDIOVASCULAR RESEARCH | 2014年 / 102卷 / 03期
关键词：
SMOOTH-MUSCLE-CELLS; ANTIPLATELET THERAPY; PLATELETS; CHALLENGES; EXPRESSION; P2Y12;
D O I：
10.1093/cvr/cvu108
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 341
页数：3
相关论文
共 50 条
  • [21] The role of P2Y12 receptors in animal models of Parkinson's disease
    Sperlagh, B.
    Baranyi, M.
    Goloncser, F.
    Antal, Z.
    PURINERGIC SIGNALLING, 2018, 14 : S16 - S16
  • [22] The platelet P2Y12 receptor influences the vessel wall response to arterial injury and thrombosis
    Evans, David J. W.
    Crosdale, Daniel J.
    Judge, Heather M.
    Chamberlain, Janet
    Jetha, Karim
    Norman, Keith E.
    Francis, Sheila E.
    Storey, Robert F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A291 - A291
  • [23] Platelet P2Y12 Receptor Influences the Vessel Wall Response to Arterial Injury and Thrombosis
    Evans, D. J. W.
    Jackman, L. E.
    Chamberlain, J.
    Crosdale, D. J.
    Judge, H. M.
    Jetha, K.
    Norman, K. E.
    Francis, S. E.
    Storey, R. F.
    CIRCULATION, 2009, 119 (01) : 116 - U236
  • [24] P2Y12 receptors in control of pain and neuroinflammation
    Sperlagh, Beata
    Horvath, Gergely
    Bekoe, Katinka
    Botz, Balint
    Mueller, Christa E.
    Von Kuegelgen, Ivar
    Helyes, Zsuzsanna
    PURINERGIC SIGNALLING, 2014, 10 (04) : 688 - 689
  • [25] Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis
    Juan J. Rodriguez
    Luis E. Baron
    Oscar C. Munoz
    Jonathan J. Diaz
    Current Cardiology Reports, 2022, 24 : 87 - 91
  • [26] Role of Monotherapy with a P2Y12 Inhibitor for Secondary Prevention in Patients with Established Atherosclerosis
    Rodriguez, Juan J.
    Baron, Luis E.
    Munoz, Oscar C.
    Diaz, Jonathan J.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (02) : 87 - 91
  • [27] Role of P2Y12 Receptor in Thrombosis
    Zhang, Yaqi
    Zhang, Si
    Ding, Zhongren
    THROMBOSIS AND EMBOLISM: FROM RESEARCH TO CLINICAL PRACTICE, VOL 1, 2017, 906 : 307 - 324
  • [28] Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors
    Masyuk, Anatoliy I.
    Gradilone, Sergio A.
    Banales, Jesus M.
    Huang, Bing Q.
    Masyuk, Tatyana V.
    Lee, Seung-Ok
    Splinter, Patrick L.
    Stroope, Angela J.
    LaRusso, Nicholas F.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 295 (04): : G725 - G734
  • [29] A differential role of the platelet ADP receptors P2Y1 and P2Y12 in Rac activation
    Soulet, C
    Hechler, B
    Gratacap, MP
    Plantavid, M
    Offermanns, S
    Gachet, C
    Payrastre, B
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (10) : 2296 - 2306
  • [30] THE ROLE OF PURINERGIC P2Y12 RECEPTOR BLOCKERS ON THE ANGIOGENIC PROPERTIES OF ENDOTHELIAL CELLS: AN IN VITRO STUDY
    Korybalska, K.
    Rutkowski, R.
    Luczak, J.
    Czepulis, N.
    Karpinski, K.
    Witowski, J.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2018, 69 (04):
12345